超声心电图参数对非瓣膜性房颤相关脑栓塞的预测价值
The Value of Electrocardiographic Parameters in Predicting Non-Valvular Atrial Fibrillation-Related Stroke
摘要: 目的:探究超声心电图参数对非瓣膜性房颤相关脑栓塞的预测价值。方法:我们选取脑梗死患者210例,包括非瓣膜性房颤(NVAF)相关脑栓塞患者98例及非心源性栓塞患者112例,比较两组间差异,应用二元Logsitic回归分析筛选出NVAF相关脑栓塞的独立危险因素,绘制受试者工作特征曲线(ROC)判断各危险因素对NVAF相关脑栓塞的预测价值。结果:NVAF相关脑栓塞患者较非心源性栓塞患者左房内径水平高,左室射血分数水平低。二元Logistic分析显示左房内径(OR = 17.159, 95%CI: 4.429~66.471, P < 0.001)及左室射血分数(OR = 0.899, 95%CI: 0.824~0.98, P = 0.016)是NVAF相关脑栓塞的独立危险因素。左房内径、左室射血分数及两种指标联合模型预测NVAF相关脑栓塞患者的受试者工作特征(ROC)曲线下面积分别为0.826、0.658、0.846 (P < 0.001)。结论:超声心动图参数对预测NVAF相关脑栓塞有显著价值,尤其是左房内径。左房内径及左室射血分数可作为早期发现NVAF相关卒中患者的筛查工具。
Abstract: Objective: To investigate the value of electrocardiographic parameters in predicting non-valvular atrial fibrillation-related stroke. Materials and Methods: A total of 210 patients with acute ischemic stroke, including 98 patients with non-valvular atrial fibrillation (NVAF)-related stroke and 112 pa-tients with non-cardiogenic embolism were selected. The differences between the two groups were compared, and independent risk factors of NVAF-related stroke were screened using binary logistic regression analysis. The diagnostic value of risk factors for NVAF-related stroke was determined by plotting the receiver operating characteristic (ROC) curves. Results: Patients with NVAF-related stroke had higher levels of left atrial diameter and lower levels of left ventricular ejection fraction than those with non-cardiogenic embolism. Binary logistic regression analysis indicated that left atrial diameter (LAD) (OR = 17.159, 95%CI: 4.429~66.471, P < 0.001) and left ventricular ejection fraction (LVEF) (OR = 0.899, 95%CI: 0.824~0.98, P = 0.016) were independent risk factors for NVAF-related stroke. The areas under the ROC curve for LAD, LVEF, and the combined model of two indicators were 0.826, 0.658, and 0.846, respectively, that predicted the incidence of NVAF-related stroke (P < 0.001). Conclusions: Echocardiographic parameters have significant value in predicting NVAF-related cerebral embolism, especially LAD. LAD and LVEF could be used as screening tools to identify NVAF-related stroke patients early.
文章引用:宋文豪, 刘长根, 解霖霖. 超声心电图参数对非瓣膜性房颤相关脑栓塞的预测价值[J]. 临床医学进展, 2022, 12(5): 4257-4263. https://doi.org/10.12677/ACM.2022.125616

参考文献

[1] January, C., et al. (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: Exec-utive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation, 130, 2071-2104. [Google Scholar] [CrossRef
[2] January, C., et al. (2019) 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration with the Society of Thoracic Surgeons. Circulation, 140, e125-e151. [Google Scholar] [CrossRef
[3] Glader, E., Sjölander, M., Eriksson, M. and Lundberg, M. (2010) Persistent Use of Secondary Preventive Drugs Declines Rapidly during the First 2 Years after Stroke. Stroke, 41, 397-401. [Google Scholar] [CrossRef
[4] Alkhouli, M. and Friedman, P. (2019) Ischemic Stroke Risk in Patients with Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week. Journal of the American College of Cardiology, 74, 3050-3065. [Google Scholar] [CrossRef] [PubMed]
[5] Andrade, J., et al. (2018) 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. The Canadian Journal of Cardiology, 34, 1371-1392. [Google Scholar] [CrossRef] [PubMed]
[6] Kirchhof, P., et al. (2016) 2016 ESC Guidelines for the Manage-ment of Atrial Fibrillation Developed in Collaboration with EACTS. European Heart Journal, 37, 2893-2962. [Google Scholar] [CrossRef] [PubMed]
[7] Yaghi, S. & Kamel, H. (2017) Stratifying Stroke Risk in Atrial Fi-brillation: Beyond Clinical Risk Scores. Stroke, 48, 2665-2670. [Google Scholar] [CrossRef
[8] Kornej, J., Apostolakis, S., Bollmann, A. and Lip, G. (2013) The Emerging Role of Biomarkers in Atrial Fibrillation. The Canadian Journal of Cardiology, 29, 1181-1193. [Google Scholar] [CrossRef] [PubMed]
[9] Beigel, R., Wunderlich, N., Ho, S., Arsanjani, R. and Siegel, R. (2014) The Left Atrial Appendage: Anatomy, Function, and Noninvasive Evaluation. JACC. Cardiovascular Imaging, 7, 1251-1265. [Google Scholar] [CrossRef] [PubMed]
[10] Shimamoto, K., et al. (2021) Echocardiographic Predictors of Car-dioembolic Stroke Due to Underlying Atrial Fibrillation: Reliable Left Atrial Remodeling Signs in Acute Stroke. Journal of the Neurological Sciences, 427, Article ID: 117514. [Google Scholar] [CrossRef] [PubMed]
[11] Montaner, J., et al. (2008) Etiologic Diagnosis of Ischemic Stroke Subtypes with Plasma Biomarkers. Stroke, 39, 2280- 2287. [Google Scholar] [CrossRef
[12] Rosenberg, M., Gottdiener, J., Heckbert, S. and Mukamal, K. (2012) Echocardiographic Diastolic Parameters and Risk of Atrial Fibrillation: The Cardiovascular Health Study. Eu-ropean Heart Journal, 33, 904-912. [Google Scholar] [CrossRef] [PubMed]
[13] Toh, N., et al. (2010) Left Atrial Volume Combined with Atrial Pump Function Identifies Hypertensive Patients with a History of Paroxysmal Atrial Fibrillation. Hypertension (Dallas, Tex.: 1979), 55, 1150-1156. [Google Scholar] [CrossRef
[14] Kourliouros, A., Savelieva, I., Kiotsekoglou, A., Jahangiri, M. and Camm, J. (2009) Current Concepts in the Pathogenesis of Atrial Fibrillation. American Heart Journal, 157, 243-252. [Google Scholar] [CrossRef] [PubMed]
[15] Kubota, T., et al. (2009) Evaluation of Left Atrial De-generation for the Prediction of Atrial Fibrillation: Usefulness of Integrated Backscatter Transesophageal Echocardiog-raphy. JACC. Cardiovascular Imaging, 2, 1039-1047. [Google Scholar] [CrossRef] [PubMed]
[16] Wozakowska-Kapłon, B. (2005) Changes in Left Atrial Size in Pa-tients with Persistent Atrial Fibrillation: A Prospective Echocardiographic Study with a 5-Year Follow-Up Period. Inter-national Journal of Cardiology, 101, 47-52. [Google Scholar] [CrossRef] [PubMed]
[17] Andrade, J.G., et al. (2020) The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. Canadian Journal of Cardiology, 36, 1847-1948. [Google Scholar] [CrossRef] [PubMed]
[18] Ruff, C., et al. (2014) Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in Patients with Atrial Fibrillation: A Meta-Analysis of Randomised Trials. The Lancet (London, England), 383, 955-962. [Google Scholar] [CrossRef